Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
Harry Bartelink(Radboud University Nijmegen), M. Piérart(European Organisation for Research and Treatment of Cancer), I. Barillot(Université de Tours), H. Struikmans(Radboud University Nijmegen), Alain Fourquet(Radboud University Nijmegen), Laurence Collette(GlaxoSmithKline (Belgium)), J.J. Jager(Radboud University Nijmegen), Walter Van den Bogaert(Radboud University Nijmegen), W.J. Hoogenraad(Radboud University Nijmegen), Jean-Claude Horiot(Radboud University Nijmegen), Jacques Borger(The Netherlands Cancer Institute), Philip Poortmans(Université Paris Sciences et Lettres)
Cited by 950
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k